antazoline
Trade name: vasocon-a
Small moleculeapproved
Approved
Apr 30, 1990
Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Antazoline in combination with naphazoline (VASOCON-A®) is indicated to relieve the symptoms of allergic conjunctivitis. — NCATS
Clinical trial activity
2 trials · 2 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Jan 1, 2009 (NCT01380678)
Timeline
1990s
- Apr 30, 1990
Ciba-Geigy — Earliest FDA Approval
- Apr 30, 1990
Ciba-Geigy — NDA Organization
2000s
- Jan 1, 2009
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Histamine H1 receptorANTAGONIST
HRH1 antagonist
Approval history
- approvedApr 30, 1990
Chemistry & pharmacology
Loading structure…
SMILES
C(N(CC1=CC=CC=C1)C2=CC=CC=C2)C3=NCCN3- Mol. weight
- 265.3529 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Discontinued
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaAntazoline ↗
- NCATSDHA8014SS1 ↗
- ChEMBLCHEMBL1305 ↗
- ChEMBLCHEMBL1257024 ↗
- ChEMBLCHEMBL9967 ↗
- ChEMBLCHEMBL1200550 ↗
- ChEMBLCHEMBL1256819 ↗
- ChEMBLCHEMBL1531864 ↗
Also known as
- antaz hcl
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline
- antazoline hcl
- antazoline hcl
- antazoline hcl
- antazoline hydrochloride
- antazoline hydrochloride
- antazoline hydrochloride
- antaz sulf
- phenazoline
- r.b.c.
- vasocon-a
- vasocon-a
- vasocon-a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01527279 | Phase 4 | Nov 1, 2012 | Institute of Cardiology, Warsaw, Poland |
| NCT01380678 | Phase 3 | Jan 1, 2009 | KhonKaen University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institute of Cardiology, Warsaw, Poland | Academic/Hospital | 1 | 1 | 1 | 2012 |
| KhonKaen University | Academic/Hospital | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Ciba-Geigy | For profit | NDA | Apr 30, 1990 |